A 76-year-old man presented with leukostasis syndrome, including oculodynia, blurred vision, and visual field defects, due to mantle cell lymphoma, prolymphocytoid variant, with marked leukocytosis, 1227 × 109/l. He had splenomegaly but no lymphadenopathy or hepatomegaly. The tumor cells were CD5+, CD19+, CD20+, FMC-7+, and kappa light chain restricted. Immunohistochemistry showed expression of p53 and of cyclin D1. Fluorescent in situ hybridization demonstrated t(11;14) with translocation between CYCLIN D1 and the immunoglobulin heavy-chain genes. The patient received leukapheresis and aggressive chemotherapy, but the leukocyte count remained above 100 × 109/l. The patient's condition rapidly deteriorated with lymphomatous infiltration of his lungs and soft tissues, and he expired 6 months after diagnosis. While it is known that mantle cell lymphoma may have a leukemic phase, the degree of leukocytosis in this case exceeds that previously reported in the literature and resulted in a clinical syndrome of leukostasis.
CITATION STYLE
Smith, M. D., Singleton, T. P., Balaraman, S., Jaiyesimi, I., O’Malley, B., Al-Saadi, A., & Mattson, J. C. (2004). Case report: Mantle cell lymphoma, prolymphocytoid variant, with leukostasis syndrome. Modern Pathology, 17(7), 879–883. https://doi.org/10.1038/modpathol.3800139
Mendeley helps you to discover research relevant for your work.